| A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling? C Fersing, A Bouhlel, C Cantelli, P Garrigue, V Lisowski, B Guillet Molecules 24 (16), 2866, 2019 | 74 | 2019 |
| Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity C Fersing, L Basmaciyan, C Boudot, J Pedron, S Hutter, A Cohen, ... ACS Medicinal Chemistry Letters 10 (1), 34-39, 2018 | 43 | 2018 |
| 4-Thiophenoxy-2-trichloromethyquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum P Verhaeghe, A Dumètre, C Castera-Ducros, S Hutter, M Laget, C Fersing, ... Bioorganic & medicinal chemistry letters 21 (19), 6003-6006, 2011 | 40 | 2011 |
| Thienopyrimidine: A promising Scaffold to access anti-infective agents P Lagardère, C Fersing, N Masurier, V Lisowski Pharmaceuticals 15 (1), 35, 2021 | 29 | 2021 |
| Stability studies of five anti-infectious eye drops under exhaustive storage conditions C Curti, E Lamy, N Primas, C Fersing, C Jean, P Bertault-Peres, P Vanelle Die Pharmazie-An International Journal of Pharmaceutical Sciences 72 (12 …, 2017 | 22 | 2017 |
| 8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi C Fersing, C Boudot, C Castera-Ducros, E Pinault, S Hutter, ... European Journal of Medicinal Chemistry 202, 112558, 2020 | 20 | 2020 |
| 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl) imidazo [1, 2-a] pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases C Fersing, C Boudot, J Pedron, S Hutter, N Primas, C Castera-Ducros, ... European journal of medicinal chemistry 157, 115-126, 2018 | 20 | 2018 |
| Stability studies of antipyocyanic beta-lactam antibiotics used in continuous infusion C Curti, HK Souab, E Lamy, F Mathias, C Bornet, B Guinard, C Fersing, ... Die Pharmazie-An International Journal of Pharmaceutical Sciences 74 (6 …, 2019 | 15 | 2019 |
| 225Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic L Rubira, E Deshayes, L Santoro, PO Kotzki, C Fersing Pharmaceutics 15 (4), 1051, 2023 | 14 | 2023 |
| Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic … C Fersing, C Boudot, R Paoli-Lombardo, N Primas, E Pinault, S Hutter, ... European Journal of Medicinal Chemistry 206, 112668, 2020 | 14 | 2020 |
| AAZTA-derived chelators for the design of innovative radiopharmaceuticals with theranostic applications C Fersing, N Masurier, L Rubira, E Deshayes, V Lisowski Pharmaceuticals 15 (2), 234, 2022 | 11 | 2022 |
| Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems LM Rečnik, C Cantelli, C Fersing, C Gongora, JP Pouget, V Lisowski Bioorganic & Medicinal Chemistry Letters 30 (22), 127527, 2020 | 8 | 2020 |
| Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices E Deshayes, C Fersing, C Thibault, M Roumiguie, P Pourquier, N Houédé Cancers 15 (12), 3133, 2023 | 7 | 2023 |
| Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu] Lu-DOTATATE: One Step Closer to Personalized Medicine K Hebert, L Santoro, M Monnier, F Castan, I Berkane, E Assénat, ... Journal of Nuclear Medicine 65 (6), 923-930, 2024 | 6 | 2024 |
| Have you looked for “stranger things” in your automated PET dose dispensing system? A process and operators qualification scheme T Martin, A Moyon, C Fersing, E Terrier, A Gouillet, F Giraud, B Guillet, ... EJNMMI Radiopharmacy and Chemistry 4, 1-8, 2019 | 3 | 2019 |
| [68Ga] Ga-FAPI-46 synthesis on a GAIA® module system: Thorough study of the automated radiolabeling reaction conditions L Rubira, C Donzé, J Fouillet, B Algudo, PO Kotzki, E Deshayes, ... Applied Radiation and Isotopes 206, 111211, 2024 | 2 | 2024 |
| Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean? MC Eberlé, C Fersing, S Guillemard, D Ilonca, S Guiu, E Deshayes Diagnostics 12 (4), 934, 2022 | 2 | 2022 |
| Lumbosacral Plexus Neurolymphomatosis: A Typical: 18: FDG PET/CT Pattern to Recognize K Bordeau, MC Eberlé, M Fabbro, C Fersing, E Deshayes Clinical Nuclear Medicine 47 (4), 352-353, 2022 | 2 | 2022 |
| Update on glasdegib in acute myeloid leukemia–broadening horizons of Hedgehog pathway inhibitors C Fersing, F Mathias Acta Pharmaceutica 72 (1), 9-34, 2022 | 2 | 2022 |
| Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators C Fersing, E Deshayes, S Langlet, L Calas, V Lisowski, PO Kotzki EJNMMI Radiopharmacy and Chemistry 6, 1-12, 2021 | 2 | 2021 |
